Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...

A confirmed H1N1 outbreak has hit Anum Senior High School, with all nine samples from the school testing positive.

B.C.'s provincial health officer is one of 10 new Order of Canada appointees, Gov. Gen. Mary Simon announced Monday.The ...

Nine students of Anum Senior High School in the Asuogyaman District of the Eastern Region have tested positive for the H1N1 ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Investing.com -- Moderna Inc (BMV: MRNA) (NASDAQ: MRNA) stock jumped 3.8% following positive Phase 3 efficacy results for its seasonal influenza vaccine candidate, which demonstrated superior ...

US mRNA specialist Moderna today announced positive results from a Phase III efficacy study (P304) evaluating the relative ...

Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.